• Guest - w'd love to know what you think about the forum! Take the 2025 Survey »

Search Results

  1. A

    2.4mg semaglutide lost 17.4% in 68 weeks

    Weekly subcutaneous injections of 2.4 mg semaglutide were administered to 902 obese or overweight patients with comorbidities. After a 20-week run-in period, 803 patients achieved the target dose of 2.4mg, and their average body weight decreased from 107.2kg to 96.1kg; subsequently, these...
Back
Top